Business Description
Medesis Pharma SA
ISIN : FR0010844464
Share Class Description:
XPAR:ALMDP: Ordinary SharesCompare
Compare
Traded in other countries / regions
ALMDP.France76D.Germany IPO Date
2021-02-12Description
Medesis Pharma SA is a clinical development stage biopharmaceutical company. It is engaged in the development of orally administered molecule drug candidates to expand therapeutic usefulness to address major unmet medical needs.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.02 | |||||
| Equity-to-Asset | -2.42 | |||||
| Debt-to-Equity | -0.21 | |||||
| Debt-to-EBITDA | -0.34 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -24.16 | |||||
| Beneish M-Score | -6.5 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 6.3 | |||||
| 3-Year EBITDA Growth Rate | -54.5 | |||||
| 3-Year EPS without NRI Growth Rate | -58.3 | |||||
| 3-Year Book Growth Rate | -22.5 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 34.07 | |||||
| 9-Day RSI | 31.9 | |||||
| 14-Day RSI | 35.2 | |||||
| 6-1 Month Momentum % | -57.16 | |||||
| 12-1 Month Momentum % | -59.48 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.36 | |||||
| Quick Ratio | 0.33 | |||||
| Cash Ratio | 0.01 | |||||
| Days Inventory | 27.62 | |||||
| Days Payable | 287.87 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -5.6 | |||||
| Shareholder Yield % | 77.73 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -3277.78 | |||||
| Operating Margin % | -5606.35 | |||||
| Net Margin % | -4974.6 | |||||
| ROA % | -163.37 | |||||
| ROIC % | -773.94 | |||||
| ROC (Joel Greenblatt) % | -2607.81 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 0.17 | |||||
| PS Ratio | 26.25 | |||||
| EV-to-EBIT | -0.79 | |||||
| EV-to-EBITDA | -0.85 | |||||
| EV-to-Revenue | 42.89 | |||||
| Earnings Yield (Greenblatt) % | -126.98 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Medesis Pharma SA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.063 | ||
| EPS (TTM) (€) | -0.626 | ||
| Beta | 0.99 | ||
| Volatility % | 120.21 | ||
| 14-Day RSI | 35.2 | ||
| 14-Day ATR (€) | 0.022381 | ||
| 20-Day SMA (€) | 0.3362 | ||
| 12-1 Month Momentum % | -59.48 | ||
| 52-Week Range (€) | 0.3 - 2.4 | ||
| Shares Outstanding (Mil) | 5.15 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Medesis Pharma SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Medesis Pharma SA Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Medesis Pharma SA Frequently Asked Questions
What is Medesis Pharma SA(XPAR:ALMDP)'s stock price today?
The current price of XPAR:ALMDP is €0.32. The 52 week high of XPAR:ALMDP is €2.40 and 52 week low is €0.30.
When is next earnings date of Medesis Pharma SA(XPAR:ALMDP)?
The next earnings date of Medesis Pharma SA(XPAR:ALMDP) is .
Does Medesis Pharma SA(XPAR:ALMDP) pay dividends? If so, how much?
Medesis Pharma SA(XPAR:ALMDP) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers